Ally Bridge Group and LifeTech Scientific Form China-Global Medtech Investment and Operating Partnership
Summary
This strategic partnership breaks new ground in coupling investments in -- with operational value-add to -- global medtech companies entering the China healthcare market.""2017 marks a turning point for Chinas FDA approval policies and process, which opens up unprecedented opportunities for overseas life science companies entering the China market, from which the ABG-LifeTech partnership is uniquely positioned and equipped to work with global medtech companies to benefit."ABG has expertise in cementing strategic partnerships between emerging healthcare companies and industry leaders, and across different geographies, particularly between the U.S., China and Europe.In 2016, Medtech SA, a leading French surgical robotics company, was acquired by Zimmer-Biomet several months after ABGs investment.LifeTech has extensive global sales network including 160 dealers in about 90 countries, especially in Southeast Asia, Russia, CIS and MEA.